“…We obtained B. subtilis 168 (trpC2), 1G12 (leu-2, gerE36), 1S101 (trpC2, cotA: :cat), 1S102 (trpC2, cotB: :cat), 1S103 (trpC2, cotC: :cat), 1S104 (trpC2, cotD: :cat), 1S105 (trpC2, cotE: :cat), 1S106 (trpC2, cotF: :cat), and 1S108 (trpC2, cotT: :cat) from the Bacillus genetic stock center (Ohio State University) and used them in this study. Construction of the B. subtilis cotS mutant, CB701, has been described previously [7]. The B. subtilis strains were all grown in DS medium [12] and when necessary, tetracycline was added to a ¢nal concentration of 20 mg ml 3I .…”